Lee, Sang-Eun
Sung, Ji Min
Andreini, Daniele
Al-Mallah, Mouaz H.
Budoff, Matthew J.
Cademartiri, Filippo
Chinnaiyan, Kavitha
Choi, Jung Hyun
Chun, Eun Ju
Conte, Edoardo
Gottlieb, Ilan
Hadamitzky, Martin
Kim, Yong Jin
Lee, Byoung Kwon
Leipsic, Jonathon A.
Maffei, Erica
Marques, Hugo
de Araújo Gonçalves, Pedro
Pontone, Gianluca
Shin, Sanghoon
Stone, Peter H.
Samady, Habib
Virmani, Renu
Narula, Jagat
Berman, Daniel S.
Shaw, Leslee J.
Bax, Jeroen J.
Lin, Fay Y.
Min, James K.
Chang, Hyuk-Jae http://orcid.org/0000-0002-6139-7545
Clinical trials referenced in this document:
Documents that mention this clinical trial
Per-lesion versus per-patient analysis of coronary artery disease in predicting the development of obstructive lesions: the Progression of AtheRosclerotic PlAque DetermIned by Computed TmoGraphic Angiography Imaging (PARADIGM) study
https://doi.org/10.1007/s10554-020-01960-z
Funding for this research was provided by:
National Research Foundation of Korea (No.2018-0-00861, 2012027176)
Department of Radiology and Biomedical Imaging, University of California, San Francisco
Michael Wolk Foundation
Article History
Received: 22 June 2020
Accepted: 30 July 2020
First Online: 10 August 2020
Compliance with ethical standards
:
: Dr. Chang receives funding from the Leading Foreign Research Institute Recruitment Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Science and ICT (MSIT) (Grant No. 2012027176). Dr. James K. Min receives funding from the Dalio Foundation, National Institutes of Health, and GE Healthcare. Dr. Min serves on the scientific advisory board of Arineta and GE Healthcare, and has an equity interest in Cleerly. Dr. Habib Samady serves on the scientific advisory board of Philips, has equity interest in Covanos Inc., and has a research grant from Medtronic. The remaining authors have no relevant disclosures.
: The study protocol was approved by the institutional review boards of all participating centers.
: The requirement of consent to participate was waived by relevant local Ethics Committees.